Effects of calcium-vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial
The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Abstract
Aims/hypothesis This study was performed to assess the effects of vitamin D and calcium supplementation on the metabolic profiles of vitamin D insufficient persons with type 2 diabetes.Methods In a parallel designed randomised placebo-controlled clinical trial, a total of 118 non-smoker individuals with type 2 diabetes and insufficient 25-hydroxyvitamin D, aged >30 years, were recruited from the Isfahan Endocrine and Metabolism Research Centre. Participants were randomly assigned to four groups receiving: (1) 50,000 U/week vitamin D + calcium placebo; (2) 1,000 mg/day calcium + vitamin D placebo; (3) 50,000 U/week vitamin D + 1,000 mg/day calcium; or (4) vitamin D placebo + calcium placebo for 8 weeks. A study technician carried out the random allocations using a random numbers table. All investigators, participants and laboratory technicians were blinded to the random assignments. All participants provided 3 days of dietary records and 3 days of physical activity records throughout the intervention. Blood samples were taken to quantify glycaemic and lipid profiles at study baseline and after 8 weeks of intervention.Results 30 participants were randomised in each group. During the intervention, one participant from the calcium group and one from the vitamin D group were excluded because of personal problems. Calcium-vitamin D co-supplementation resulted in reduced serum insulin (changes from baseline: -14.8 ± 3.9 pmol/l, p = 0.01), HbA1c [-0.70 ± 0.19% (-8.0 ± 0.4 mmol/mol), p = 0.02], HOMA-IR (-0.46 ± 0.20, p = 0.001), LDL-cholesterol (-10.36 ± 0.10 mmol/l, p = 0.04) and total/HDL-cholesterol levels (-0.91 ± 0.16, p = 0.03) compared with other groups. We found a significant increase in QUICKI (0.025 ± 0.01, p = 0.004), HOMA of beta cell function (HOMA-B; 11.8 ± 12.17, p = 0.001) and HDL-cholesterol (0.46 ± 0.05 mmol/l, p = 0.03) in the calcium-vitamin D group compared with others.Conclusions/interpretation Joint calcium and vitamin D supplementation might improve the glycaemic status and lipid profiles of vitamin D insufficient people with type 2 diabetes.Trial registration ClinicalTrials.gov NCT01662193 FUNDING: Clinical Research Council, Isfahan University of Medical Sciences, Isfahan, Iran.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 1×
“The HOMA-IR, HOMA-B and QUICKI were calculated according to the suggested equation [18, 19].”
MethodHolick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 1×
“The HOMA-IR, HOMA-B and QUICKI were calculated according to the suggested equation [18, 19].”
MethodRegulation of adiposity by dietary calcium
Zemel, M. B., Shi, H., Greer, B., Dirienzo, D., & Zemel, P. C. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1132 · Cited by 968 · cited 1×
“Calcium supplementation may also affect circulating lipid concentrations by its effect on concentrations of parathyroid hormone and vitamin D [45].”
BackgroundCalcium/Vitamin D Supplementation and Cardiovascular Events
Hsia, J., Heiss, G., Ren, H., Allison, M., Dolan, N. C., Greenland, P., Heckbert, S. R., Johnson, K. C., Manson, J. E., Sidney, S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.673491 · Cited by 662
Pittas, A. G., Harris, S. S., Stark, P. C., & Dawson-Hughes, B. (2007) · Diabetes Care · doi:10.2337/dc06-1994 · Cited by 643
Role of vitamin D in the pathogenesis of type 2 diabetes mellitus
Palomer, X., González‐Clemente, J. M., Blanco‐Vaca, F., & Mauricio, D. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00710.x · Cited by 509 · cited 1×
“The effects of vitamin D or calcium on diabetes have mostly been examined independently in previous studies [9].”
BackgroundImpaired insulin secretory capacity in mice lacking a functional vitamin D receptor
Zeitz, U., Weber, K., Soegiarto, D. W., Wolf, E., Balling, R., & Erben, R. G. (2003) · The FASEB Journal · doi:10.1096/fj.02-0424fje · Cited by 445 · cited 1×
“Vitamin D may have a direct effect mediated by the binding of calcitriol to the vitamin D receptor expressed in beta cells [35, 36].”
BackgroundMitri, J., Dawson-Hughes, B., Hu, F. B., & Pittas, A. G. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.011684 · Cited by 426
Identification of a Vitamin D response element in the human insulin receptor gene promoter
Maestro, B., Dávila, N., Carranza, M. C., & Calle, C. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00032-3 · Cited by 377 · cited 1×
“The presence of the vitamin D response element in the human insulin gene promoter and transcriptional activation of the human insulin gene might further support the direct effect of vitamin D on insulin synthesis and secretion [37].”
BackgroundVitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids
Jorde, R., & Grimnes, G. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.05.001 · Cited by 358 · cited 1×
“So far, some intervention studies, with divergent findings, have examined the effects of vitamin D or calcium supplementation on lipid profiles [12, 30, 31].”
ResultKayaniyil, S., Vieth, R., Retnakaran, R., Knight, J. A., Qi, Y., Gerstein, H. C., Perkins, B. A., Harris, S. B., Zinman, B., & Hanley, A. J. (2010) · Diabetes Care · doi:10.2337/dc09-2321 · Cited by 346 · cited 2×
“syndrome [3], cardiovascular disease [4] and type 2 diabetes [5], by improving pancreatic beta cell function, peripheral insulin sensitivity [6] and lipid profiles [4].”
BackgroundBelenchia, A. M., Tosh, A. K., Hillman, L. S., & Peterson, C. A. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.050013 · Cited by 328 · cited 1×
“However, in a clinical trial, correction of poor vitamin D status through dietary supplementation with 4,000 U vitamin D3/day for 6 months resulted in reduced insulin resistance in obese adolescent patients [26].”
BackgroundVitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men
Lind, L., Hänni, A., Lithell, H., Hvarfner, A., Sörensen, O. H., & Ljunghall, S. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00154-h · Cited by 317 · cited 1×
“The potential mechanism through which vitamin D might affect lipid concentrations could be mediated through its potential effect on insulin sensitivity as well as on calcium metabolism [46].”
BackgroundLi, K., Kaaks, R., Linseisen, J., & Rohrmann, S. (2012) · Heart · doi:10.1136/heartjnl-2011-301345 · Cited by 314 · cited 1×
“It is worth mentioning that the dose of calcium supplementation should be considered in calcium intervention studies because some investigations have reported a significant direct association between calcium intake and cardiovascular mortality [32].”
BackgroundThe role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro
Milner, R. D. G., & Hales, C. N. (1967) · Diabetologia · doi:10.1007/bf01269910 · Cited by 307 · cited 1×
“Insulin secretion, a calcium-dependent process, might be adversely influenced through alterations in calcium flux [40].”
BackgroundDietary Calcium and Blood Pressure: A Meta-Analysis of Randomized Clinical Trials
Allender, P. S., Cutler, J. A., Follmann, D., Cappuccio, F. P., Pryer, J., & Elliott, P. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-9-199605010-00007 · Cited by 306
Johnson, J. A., Grande, J. P., Roche, P. C., & Kumar, R. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.3.e356 · Cited by 292 · cited 1×
“Vitamin D may have a direct effect mediated by the binding of calcitriol to the vitamin D receptor expressed in beta cells [35, 36].”
BackgroundTranscriptional activation of the human insulin receptor gene by 1,25‐dihydroxyvitamin D3
Maestro, B., Molero, S., Bajo, S., Dávila, N., & Calle, C. (2002) · Cell Biochemistry and Function · doi:10.1002/cbf.951 · Cited by 288 · cited 1×
“In peripheral insulin-target cells, active vitamin D metabolites may enhance insulin sensitivity in several ways, including an increase in the expression of insulin receptors, the activation of transcription factors important in glucose homeostasis, or indirectly via the regulation of calcium [39].”
BackgroundNikooyeh, B., Neyestani, T. R., Farvid, M., Alavi-Majd, H., Houshiarrad, A., Kalayi, A., Shariatzadeh, N., Gharavi, A., Heravifard, S., Tayebinejad, N., et al. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.007336 · Cited by 277 · cited 1×
“In a randomised clinical trial [33], daily intake of a vitamin-D-fortified yogurt drink, with or without added calcium, led to a decrease in BMI and waist circumference in people with type 2 diabetes.”
BackgroundDenke, M. A., Fox, M. M., & Schulte, M. C. (1993) · The Journal of Nutrition · doi:10.1093/jn/123.6.1047 · Cited by 264
Major, G. C., Alarie, F. P., Doré, J., Phouttama, S., & Tremblay, A. (2007) · PubMed · doi:10.1093/ajcn/85.1.54 · Cited by 251
Serum 25-Hydroxyvitamin D, Calcium Intake, and Risk of Type 2 Diabetes After 5 Years
Gagnon, C., Lu, Z. X., Magliano, D. J., Dunstan, D. W., Shaw, J. E., Zimmet, P. Z., Sikaris, K., Grantham, N., Ebeling, P. R., & Daly, R. M. (2011) · Diabetes Care · doi:10.2337/dc10-2167 · Cited by 241
Saneei, P., Salehi‐Abargouei, A., & Esmaillzadeh, A. (2013) · Obesity Reviews · doi:10.1111/obr.12016 · Cited by 217
Self-citationGerstl, E.-M., Rabl, W., Rosenbauer, J., Gröbe, H., Hofer, S. E., Krause, U., & Holl, R. W. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-007-0586-9 · Cited by 201
1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line
Sergeev, I. N. (1995) · Endocrinology · doi:10.1210/en.136.7.2852 · Cited by 192 · cited 1×
“An indirect effect of vitamin D on the pancreatic beta cell may be mediated via its regulation of calcium that, in turn, affects insulin secretion [38].”
BackgroundGanji, V., Zhang, X., Shaikh, N., & Tangpricha, V. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.013516 · Cited by 189 · cited 1×
“syndrome [3], cardiovascular disease [4] and type 2 diabetes [5], by improving pancreatic beta cell function, peripheral insulin sensitivity [6] and lipid profiles [4].”
BackgroundYiu, Y.-F., Yiu, K.-H., Siu, C.-W., Chan, Y.-H., Li, S.-W., Wong, L.-Y., Lee, S. W. L., Tam, S., Wong, E. W. K., Lau, C.-P., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.12.013 · Cited by 182 · cited 1×
“Another study has shown that in patients with type 2 diabetes, 12 weeks of oral supplementation with 5,000 U/day vitamin D did not significantly affect vascular function or serum biomarkers of inflammation and oxidative stress [25].”
BackgroundSun, G., Vasdev, S., Martin, G. R., Gadag, V., & Zhang, H. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3336 · Cited by 163
Vitamin D Status in Relation to Glucose Metabolism and Type 2 Diabetes in Septuagenarians
Dalgård, C., Petersen, M. S., Weihe, P., & Grandjean, P. (2011) · Diabetes Care · doi:10.2337/dc10-2084 · Cited by 152 · cited 1×
“There have been many reports indicating a significant association between vitamin D status and beta cell function [6], plasma glucose level [20] and insulin sensitivity [21].”
BackgroundEffect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus.
Inomata, S., Kadowaki, S., Yamatani, T., Fukase, M., & Fujita, T. (1986) · PubMed · Cited by 119
Rajpathak, S. N., Xue, X., Wassertheil-Smoller, S. W., Horn, L. V., Robinson, J. G., Liu, S., Allison, M., Martin, L. W., Ho, G. Y. F., & Rohan, T. E. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28579 · Cited by 109 · cited 2×
“We are aware of only a few intervention studies that investigated the combined effects of calcium–vitamin D supplements on lipid profiles [13, 14].”
BackgroundCholesterol Metabolism Is Affected by Calcium Phosphate Supplementation in Humans
Ditscheid, B., Keller, S., & Jahreis, G. (2005) · Journal of Nutrition · doi:10.1093/jn/135.7.1678 · Cited by 107 · cited 1×
“So far, some intervention studies, with divergent findings, have examined the effects of vitamin D or calcium supplementation on lipid profiles [12, 30, 31].”
ResultGannagé‐Yared, M., Azoury, M., Mansour, I., Baddoura, R., Halaby, G., & Naaman, R. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03347358 · Cited by 100
No effect of calcitriol on insulin‐mediated glucose uptake in healthy subjects
FLISER, D., STEFANSKI, A., FRANEK, E., FODE, P., GUDARZI, A., & RITZ, E. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1520699.x · Cited by 99 · cited 1×
“In a short-term clinical trial, supplementation with calcitriol for 7 days did not influence fasting glycaemia or insulin sensitivity [24].”
BackgroundAl‐Daghri, N. M., Alkharfy, K. M., Al-Othman, A. M., El-Kholie, E. M., Moharram, O. A., Alokail, M. S., Al‐Saleh, Y., Sabico, S., Kumar, S., & Chrousos, G. P. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-85 · Cited by 94 · cited 1×
“1 nmol/l [17]), we needed 104 patients to be enrolled.”
BackgroundGlucose Tolerance and Insulin Secretion in Patients with Parathyroid Disorders
Yasuda, K., Hurukawa, Y., Okuyama, M., Kikuchi, M., & Yoshinaga, K. (1975) · New England Journal of Medicine · doi:10.1056/nejm197503062921003 · Cited by 92 · cited 1×
“Earlier studies have also indicated a link between hypocalcaemia and impairment of insulin release in those without diabetes [42].”
BackgroundSánchez, M., de la Sierra, A., Coca, A., Poch, E., Giner, V., & Urbano-Márquez, A. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.531 · Cited by 91
Beaulieu, C., Kestekian, R., Havrankova, J., & Gascon-Barré, M. (1993) · Diabetes · doi:10.2337/diab.42.1.35 · Cited by 82 · cited 1×
“In an experimental study in vitamin-D-depleted rats, calcium repletion alone led to normalised glucose tolerance and insulin secretion [41].”
BackgroundGlycated Haemoglobin Is Inversely Related to Serum Vitamin D Levels in Type 2 Diabetic Patients
Zoppini, G., Galletti, A. M. R., Targher, G., Brangani, C., Pichiri, I., Negri, C., Stoico, V., Cacciatori, V., & Bonora, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082733 · Cited by 72 · cited 8×
“However, calcium–vitamin D supplementation led to a significant decrease in serum insulin (changes from baseline: −14.8±3.9 pmol/l, p=0.01) and HbA1c [−0.70±0.19% (−8.0±0.4 mmol/mol), p=0.02] compared with other groups.”
BackgroundInfluentialVitamin D and Cardiovascular Disease: A Novel Agent for Reducing Cardiovascular Risk?
Anagnostis, P., G. Athyros, V., Adamidou, F., Florentin, M., & Karagiannis, A. (2010) · Current Vascular Pharmacology · doi:10.2174/157016110792006978 · Cited by 64 · cited 2×
“Optimal vitamin D status may influence cardiovascular health through improving lipid profiles [4].”
BackgroundZhou, J., Zhao, L.-J., Watson, P., Zhang, Q., & Lappe, J. M. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-62 · Cited by 51
Harris, S. S. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.003491 · Cited by 45 · cited 1×
“syndrome [3], cardiovascular disease [4] and type 2 diabetes [5], by improving pancreatic beta cell function, peripheral insulin sensitivity [6] and lipid profiles [4].”
BackgroundUlutaş, Ö., Taşkapan, H., Taşkapan, M. Ç., & Temel, İ. (2012) · International Urology and Nephrology · doi:10.1007/s11255-012-0308-8 · Cited by 29 · cited 1×
“Cholecalciferol replacement therapy significantly decreased HOMA-IR and improved glycaemic indices in vitamin D insufficient dialysis patients with type 2 diabetes [28].”
BackgroundJolma, P., Kööbi, P., Kalliovalkama, J., Kähönen, M. A. P., Fan, M., Saha, H. H. T., Helin, H., Lehtimäki, T. J., & Pörsti, I. H. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01148.2002 · Cited by 25 · cited 1×
“The beneficial effects of calcium supplementation on circulating concentrations of lipoproteins are supported by animal studies [43].”
Background25-OH-Vitamin D and procalcitonin levels after correction of acute hyperglycemia
Usman, A. (2013) · Medical Science Monitor · doi:10.12659/msm.883880 · Cited by 16 · cited 8×
“However, calcium–vitamin D supplementation led to a significant decrease in serum insulin (changes from baseline: −14.8±3.9 pmol/l, p=0.01) and HbA1c [−0.70±0.19% (−8.0±0.4 mmol/mol), p=0.02] compared with other groups.”
BackgroundInfluentialNoda, M., & Mizoue, T. (2010) · Cited by 6
Cited by
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
Analysis of Association between Vitamin D Deficiency and Insulin Resistance
Szymczak-Pajor, I., & Śliwińska, A. (2019) · Nutrients · doi:10.3390/nu11040794 · Cited by 335
“Placebo-controlled, randomized clinical trial 118 non-smoker subjects with T2DM and vitamin D insufficiency 8 weeks 1st group: 50,000 U/week vitamin D + calcium placebo; 2nd group:1000 mg/day calcium + vitamin D placebo; 3rd group: 50,000 U/week vitamin D + 1000 mg/day calcium 4th group: vitamin D placebo + calcium pl…”
MethodAssociations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome
Wimalawansa, S. J. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.09.017 · Cited by 300
“vitamin D supplementation improved the glycemic status and lipid profiles [139].”
BackgroundLi, X., Liu, Y., Zheng, Y., Wang, P., & Zhang, Y. (2018) · Nutrients · doi:10.3390/nu10030375 · Cited by 266
“[26] and trials carrying a high risk of bias [24,26,36].”
BackgroundRejnmark, L., Bislev, L. S., Cashman, K. D., Eiríksdottir, G., Gaksch, M., Grübler, M., Grimnes, G., Gudnason, V., Lips, P., Pilz, S., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0180512 · Cited by 235
“Three studies used vitamin D in combination with calcium [87,89,91] and one study used UVB exposure [85].”
Metadata
- Authors
- Tabesh, M., Azadbakht, L., Faghihimani, E., Tabesh, M., & Esmaillzadeh, A.
- Affiliations
- Isfahan University of Medical Sciences (IR)
- Corresponding author
- Esmaillzadeh, Ahmad
- Venue
- Diabetologia
- Published
- 2014-07-10
- Volume
- 57
- Issue
- 10
- Pages
- 2038-2047
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1984741094
- Cited by
- 98
- References
- 48
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 6 · 2022: 13 · 2021: 8 · 2020: 10 · 2019: 11 · 2018: 6 · 2017: 13 · 2016: 14 · 2015: 8
- FWCI
- 8.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Food Security Research Center, Isfahan University of Medical Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutrition and Health Studies
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Keywords
- vitamin D deficiency, type 2 diabetes, insulin resistance, insulin sensitivity, HOMA-IR, QUICKI, HbA1c, LDL cholesterol, HDL cholesterol, serum insulin, lipid profile, glycemic control, dietary calcium, vitamin D intake, physical activity, vitamin D supplementation
- MeSH terms
- Blood Glucose, Calcium, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Vitamin D, Vitamin D Deficiency, Treatment Outcome, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.